- Valves
- Delivery System
Asia Pacific Transcatheter Pulmonary Valve (TPV) Therapy Market size was valued at USD x billion in 2022 and is expected to reach USD x billion by 2029 growing at a CAGR of x% during the forecast period 2023 to 2029. Transcatheter pulmonary valve replacement is a surgical procedure carried in older children and adults with congenital heart disease coupled with at least one previous operation. These valves are delivered by hollow, thin, and long tube system that delivers the transcatheter pulmonary valve into heart without open heart surgery.
Asia Pacific Transcatheter Pulmonary Valve (TPV) Therapy Market Dynamics
Increase in the R&D for the innovation of newer products, prolonged action of transcatheter pulmonary valves, increase in the prevalence of congenital heart diseases, and advances in healthcare infrastructure are expected to propel the Asia Pacific transcatheter pulmonary valve (TPV) therapy market. However, stringent regulations for product approval, high cost of therapy, and lack of skilled professionals may hinder the growth of Asia Pacific transcatheter pulmonary valve (TPV) therapy market over the forecast years.
Asia Pacific Transcatheter Pulmonary Valve (TPV) Therapy Market
Asia Pacific Transcatheter Pulmonary Valve (TPV) Therapy Market
Geographically, Asia Pacific transcatheter pulmonary valve (TPV) therapy market is segmented into Japan, China, India, Australia & New Zealand, ASEAN Countries, South Korea, and Rest of Asia Pacific. Japan transcatheter pulmonary valve therapy market is driven by increase in the R&D for the innovation of newer products, high adoption of newer devices, and sophisticated healthcare infrastructure are expected to fuel the market. Chinatranscatheter pulmonary valve therapy market expected to exhibit lucrative growth owing to increase in the prevalence of congenital heart disease, rise in healthcare expenditure, and launching of newer products in China market are propel the market. India transcatheter pulmonary valve therapy market is poised to grow at notable rate due to entry of companies into Indian market, development in healthcare infrastructure, and rise in medical tourism.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The asia pacific transcatheter pulmonary valve tpv therapy market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Asia Pacific Transcatheter Pulmonary Valve Tpv Therapy Market Segmentation
By Product Type
By End User
- Hospitals
- Cardiology Clinics
- Ambulatory Surgical Centers
Frequently Asked Questions
2023 is the base year and 2029 is the forecast year.
The report covers the asia pacific transcatheter pulmonary valve (TPV) therapy market data: China, India, Japan, Australia & New Zealand
The asia pacific transcatheter pulmonary valve (TPV) therapy market key players are Venus MedTech, Inova, Edward Lifesciences and Medtronic
| 1.Executive Summary |
| 2. Asia Pacific Transcatheter Pulmonary Valve (TPV) Therapy Market Introduction |
| 2.1. Asia Pacific Transcatheter Pulmonary Valve (TPV) Therapy Market - Taxonomy |
| 2.2. Asia Pacific Transcatheter Pulmonary Valve (TPV) Therapy Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.End User |
| 2.2.3.Country |
| 3. Asia Pacific Transcatheter Pulmonary Valve (TPV) Therapy Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Asia Pacific Transcatheter Pulmonary Valve (TPV) Therapy Market Analysis, 2018-2022 and Forecast 2023-2029 |
| 4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Asia Pacific Transcatheter Pulmonary Valve (TPV) Therapy Market By Product Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 5.1. Valves |
| 5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Delivery System |
| 5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6. Asia Pacific Transcatheter Pulmonary Valve (TPV) Therapy Market By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 6.1. Hospitals |
| 6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Cardiology Clinics |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Ambulatory Surgical Centers |
| 6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Asia Pacific Transcatheter Pulmonary Valve (TPV) Therapy Market By Country, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 7.1. China |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. India |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Australia and New Zealand (ANZ) |
| 7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Japan |
| 7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Rest of APAC |
| 7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.China Transcatheter Pulmonary Valve (TPV) Therapy Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 8.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Valves |
| 8.1.2.Delivery System |
| 8.2. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Hospitals |
| 8.2.2.Cardiology Clinics |
| 8.2.3.Ambulatory Surgical Centers |
| 9.India Transcatheter Pulmonary Valve (TPV) Therapy Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 9.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Valves |
| 9.1.2.Delivery System |
| 9.2. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Hospitals |
| 9.2.2.Cardiology Clinics |
| 9.2.3.Ambulatory Surgical Centers |
| 10.Australia and New Zealand (ANZ) Transcatheter Pulmonary Valve (TPV) Therapy Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Valves |
| 10.1.2.Delivery System |
| 10.2. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Hospitals |
| 10.2.2.Cardiology Clinics |
| 10.2.3.Ambulatory Surgical Centers |
| 11.Japan Transcatheter Pulmonary Valve (TPV) Therapy Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Valves |
| 11.1.2.Delivery System |
| 11.2. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Hospitals |
| 11.2.2.Cardiology Clinics |
| 11.2.3.Ambulatory Surgical Centers |
| 12.Rest of APAC Transcatheter Pulmonary Valve (TPV) Therapy Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Valves |
| 12.1.2.Delivery System |
| 12.2. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Hospitals |
| 12.2.2.Cardiology Clinics |
| 12.2.3.Ambulatory Surgical Centers |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Venus MedTech |
| 13.2.2.Inova |
| 13.2.3.Edward Lifesciences |
| 13.2.4.Medtronic Plc. |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
- Venus MedTech
- Inova
- Edward Lifesciences
- Medtronic Plc.